Webster M - Search Results

1

The cost effectiveness of genetic testing for CYP2C19 variants to guide thienopyridine treatment in patients with acute coronary syndromes: a New Zealand evaluation.

Panattoni L, Brown PM, Te Ao B, Webster M, Gladding P. Panattoni L, et al. Among authors: webster m. Pharmacoeconomics. 2012 Nov 1;30(11):1067-84. doi: 10.2165/11595080-000000000-00000. Pharmacoeconomics. 2012. PMID: 22974536

2

Late drug-eluting stent thrombosis and erythropoietin: cause and effect?

Gladding PA, Webster MW, Kay P. Gladding PA, et al. Among authors: webster mw. Heart Lung Circ. 2007 Aug;16(4):305-7. doi: 10.1016/j.hlc.2007.01.002. Epub 2007 Apr 18. Heart Lung Circ. 2007. PMID: 17446131

3

Clopidogrel and stent thrombosis after percutaneous coronary intervention.

Gladding P, Webster M. Gladding P, et al. Among authors: webster m. N Z Med J. 2007 Jun 1;120(1255):U2554. N Z Med J. 2007. PMID: 17546102 No abstract available.

4

The antiplatelet effect of six non-steroidal anti-inflammatory drugs and their pharmacodynamic interaction with aspirin in healthy volunteers.

Gladding PA, Webster MW, Farrell HB, Zeng IS, Park R, Ruijne N. Gladding PA, et al. Am J Cardiol. 2008 Apr 1;101(7):1060-3. doi: 10.1016/j.amjcard.2007.11.054. Epub 2008 Feb 6. Am J Cardiol. 2008. PMID: 18359332 Clinical Trial.

5

Antiplatelet drug nonresponsiveness.

Gladding P, Webster M, Ormiston J, Olsen S, White H. Gladding P, et al. Among authors: webster m. Am Heart J. 2008 Apr;155(4):591-9. doi: 10.1016/j.ahj.2007.12.034. Am Heart J. 2008. PMID: 18371464 Review.

6

The antiplatelet effect of higher loading and maintenance dose regimens of clopidogrel: the PRINC (Plavix Response in Coronary Intervention) trial.

Gladding P, Webster M, Zeng I, Farrell H, Stewart J, Ruygrok P, Ormiston J, El-Jack S, Armstrong G, Kay P, Scott D, Gunes A, Dahl ML. Gladding P, et al. Among authors: webster m. JACC Cardiovasc Interv. 2008 Dec;1(6):612-9. doi: 10.1016/j.jcin.2008.09.005. JACC Cardiovasc Interv. 2008. PMID: 19463374 Free article. Clinical Trial.

7

The pharmacogenetics and pharmacodynamics of clopidogrel response: an analysis from the PRINC (Plavix Response in Coronary Intervention) trial.

Gladding P, Webster M, Zeng I, Farrell H, Stewart J, Ruygrok P, Ormiston J, El-Jack S, Armstrong G, Kay P, Scott D, Gunes A, Dahl ML. Gladding P, et al. Among authors: webster m. JACC Cardiovasc Interv. 2008 Dec;1(6):620-7. doi: 10.1016/j.jcin.2008.09.008. JACC Cardiovasc Interv. 2008. PMID: 19463375 Free article. Clinical Trial.

8

Prasugrel STEMI subgroup analysis.

Webster MW, Gladding P. Webster MW, et al. Lancet. 2009 May 30;373(9678):1846; author reply 1846-8. doi: 10.1016/S0140-6736(09)61020-5. Lancet. 2009. PMID: 19482210 No abstract available.

9

Feasibility, safety, and efficacy of a novel polymeric pimecrolimus-eluting stent: traditional pre-clinical safety end points failed to predict 6-month clinical angiographic results.

Ormiston JA, Webster MW, Schwartz RS, Gladding P, Stewart JT, Kay IP, Ruygrok PN, Hatrick R. Ormiston JA, et al. JACC Cardiovasc Interv. 2009 Oct;2(10):1017-24. doi: 10.1016/j.jcin.2009.08.006. JACC Cardiovasc Interv. 2009. PMID: 19850264 Free article. Clinical Trial.

10

Pharmacogenetic testing for clopidogrel using the rapid INFINITI analyzer: a dose-escalation study.

Gladding P, White H, Voss J, Ormiston J, Stewart J, Ruygrok P, Bvaldivia B, Baak R, White C, Webster M. Gladding P, et al. Among authors: webster m. JACC Cardiovasc Interv. 2009 Nov;2(11):1095-101. doi: 10.1016/j.jcin.2009.08.018. JACC Cardiovasc Interv. 2009. PMID: 19926050 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,545 results

Search Page